Patents Assigned to Regeneron Pharamceuticals, Inc.
  • Methods for treating cancer by administering an anti-Ang-2 antibody
    Patent number: 8980268
    Abstract: The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: March 17, 2015
    Assignee: Regeneron Pharamceuticals, Inc.
    Inventors: Israel Lowy, Gavin Thurston, Christopher Daly